BackFrazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Common Stock

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s common stock is $280M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$278.03M
101.47% YoYΔ $140.03M vs prior year quarter

Peer trimmed avg / median

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Common Stock History

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) vs. peers: Common Stock Comparison

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) (FLACU) FAQ

The latest common stock for FLACU is $280M as of September 2022. That compares with $140M in the prior-year period — up 101.5% year over year. Investors often review this figure alongside Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, FLACU's common stock moved from $140M to $280M — a 101.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s operating scale or balance-sheet position.

A common stock figure of $280M for FLACU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FLACU's common stock ($280M), review year-over-year change from $140M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.